Lista de obras - Cécile Gouttefangeas - Dominio Público Uruguay

A Simple and Rapid Method for Quality Control of Major Histocompatibility Complex-Peptide Monomers by Flow Cytometry

artículo científico publicado en 2017

A framework for T cell assays

artículo científico publicado en 2015

A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A24 and HLA-DRB111 alleles may be prognostic and predictive biomarkers for clinical benefit

artículo científico publicado en 2015

A vaccine in renal cell carcinoma: are we nearing reality?

artículo científico publicado en 2012

AE37 peptide vaccination in prostate cancer: a 4-year immunological assessment updates on a phase I trial

artículo científico publicado en 2013

Activated integrins identify functional antigen-specific CD8+ T cells within minutes after antigen stimulation.

artículo científico publicado en 2018

Alternative variants of human HYDIN are novel cancer-associated antigens recognized by adaptive immunity

artículo científico publicado en 2013

Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation

scientific article published on 08 October 2010

CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors.

artículo científico publicado en 2004

CIMT 2009: report on the seventh annual meeting of the association for immunotherapy of cancer. June 3-5, Mainz, Germany

artículo científico publicado en 2009

CIMT 2010: Report on the eighth annual meeting of the association for cancer immunotherapy, May 26–28, 2010, Mainz, Germany ⬇️

artículo científico publicado el 23 de noviembre de 2010

Caramel flavour perception: Impact of the non-volatile compounds on sensory properties and in-vitro aroma release

artículo científico publicado en 2017

Cathepsin W expressed exclusively in CD8+ T cells and NK cells, is secreted during target cell killing but is not essential for cytotoxicity in human CTLs

artículo científico publicado en 2008

Characterisation of the volatile fraction of aromatic caramel using heart-cutting multidimensional gas chromatography

artículo científico publicado en 2014

Clonal expansion of renal cell carcinoma-infiltrating T lymphocytes

artículo científico publicado en 2013

Cryopreservation of MHC multimers: Recommendations for quality assurance in detection of antigen specific T cells

artículo científico publicado en 2014

Cytomegalovirus infection: a driving force in human T cell immunosenescence

artículo científico publicado en 2007

Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters

artículo científico publicado en 2015

Defining the critical hurdles in cancer immunotherapy

artículo científico publicado en 2011

Development of an RNA-based kit for easy generation of TCR-engineered lymphocytes to control T-cell assay performance

artículo científico publicado en 2018

Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation

artículo científico publicado en 2011

Generation of TCR-engineered T cells and their use to control the performance of T cell assays.

artículo científico publicado en 2015

Harmonization of immune biomarker assays for clinical studies

artículo científico publicado en 2011

Harmonization of the intracellular cytokine staining assay

artículo científico publicado en 2012

Hierarchical modeling for rare event detection and cell subset alignment across flow cytometry samples

artículo científico publicado en 2013

High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donors.

artículo científico publicado en 2005

Human platelets express heat shock protein receptors and regulate dendritic cell maturation

artículo científico publicado en 2002

Immunoguiding, the Final Frontier in the Immunotherapy of Cancer

Immunorejuvenation in the elderly

artículo científico publicado en 2006

Immunotherapy of renal cell carcinoma

artículo científico publicado en 2006

Impact of curative radiotherapy on the immune status of patients with localized prostate cancer

scholarly article by Franziska Eckert et al published 2018 in OncoImmunology

Integrated functional genomics approach for the design of patient-individual antitumor vaccines.

artículo científico publicado en 2002

International conference: progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain.

artículo científico publicado en 2007

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenase

artículo científico publicado en 2013

Managing Multi-center Flow Cytometry Data for Immune Monitoring

artículo científico publicado en 2014

Modeling flow cytometry data for cancer vaccine immune monitoring

artículo científico publicado en 2010

Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry

artículo científico publicado en 2015

More than just tumor destruction: immunomodulation by thermal ablation of cancer

artículo científico publicado en 2011

Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer.

artículo científico publicado en 2009

Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient

artículo científico publicado en 2016

Profiling of primary peripheral blood- and monocyte-derived dendritic cells using monoclonal antibodies from the HLDA10 Workshop in Wollongong, Australia

artículo científico publicado en 2015

Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients

artículo científico publicado en 2011

Radiofrequency ablation: the percutaneous approach

artículo científico publicado en 2006

Report on the Fifth Annual Meeting of the Association for Immunotherapy of Cancer (CIMT) April 12–14, 2007 in Würzburg, Germany

artículo científico publicado en 2008

Results of a Phase 1/2 Study in Metastatic Renal Cell Carcinoma Patients Treated with a Patient-specific Adjuvant Multi-peptide Vaccine after Resection of Metastases

artículo científico publicado en 2017

Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols.

artículo científico publicado en 2012

Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas

artículo científico publicado en 2009

Soluble heat shock protein 70 members in patients undergoing allogeneic hematopoietic cell transplantation

artículo científico publicado en 2016

T-cell dysregulation caused by chronic antigenic stress: the role of CMV in immunosenescence?

artículo científico publicado en 2006

Targeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapy

artículo científico publicado en 2014

The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study

artículo científico publicado en 2012

The fungal ligand chitin directly binds and signals inflammation dependent on oligomer size and TLR2

Thinking outside the gate: single-cell assessments in multiple dimensions

artículo científico publicado en 2015

Towards patient-specific tumor antigen selection for vaccination

artículo científico publicado en 2002

Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas.

artículo científico publicado en 2006

Validation of immunomonitoring methods for application in clinical studies: The HLA-peptide multimer staining assay

artículo científico publicado en 2016

Lista de obras de Cécile Gouttefangeas

A Simple and Rapid Method for Quality Control of Major Histocompatibility Complex-Peptide Monomers by Flow Cytometry

A framework for T cell assays

A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit

A vaccine in renal cell carcinoma: are we nearing reality?

AE37 peptide vaccination in prostate cancer: a 4-year immunological assessment updates on a phase I trial

Activated integrins identify functional antigen-specific CD8+ T cells within minutes after antigen stimulation.

Alternative variants of human HYDIN are novel cancer-associated antigens recognized by adaptive immunity

Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation

CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors.

CIMT 2009: report on the seventh annual meeting of the association for immunotherapy of cancer. June 3-5, Mainz, Germany

CIMT 2010: Report on the eighth annual meeting of the association for cancer immunotherapy, May 26–28, 2010, Mainz, Germany ⬇️

Caramel flavour perception: Impact of the non-volatile compounds on sensory properties and in-vitro aroma release

Cathepsin W expressed exclusively in CD8+ T cells and NK cells, is secreted during target cell killing but is not essential for cytotoxicity in human CTLs

Characterisation of the volatile fraction of aromatic caramel using heart-cutting multidimensional gas chromatography

Clonal expansion of renal cell carcinoma-infiltrating T lymphocytes

Cryopreservation of MHC multimers: Recommendations for quality assurance in detection of antigen specific T cells

Cytomegalovirus infection: a driving force in human T cell immunosenescence

Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters

Defining the critical hurdles in cancer immunotherapy

Development of an RNA-based kit for easy generation of TCR-engineered lymphocytes to control T-cell assay performance

Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation

Generation of TCR-engineered T cells and their use to control the performance of T cell assays.

Harmonization of immune biomarker assays for clinical studies

Harmonization of the intracellular cytokine staining assay

Hierarchical modeling for rare event detection and cell subset alignment across flow cytometry samples

High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donors.

Human platelets express heat shock protein receptors and regulate dendritic cell maturation

Immunoguiding, the Final Frontier in the Immunotherapy of Cancer

Immunorejuvenation in the elderly

Immunotherapy of renal cell carcinoma

Impact of curative radiotherapy on the immune status of patients with localized prostate cancer

Integrated functional genomics approach for the design of patient-individual antitumor vaccines.

International conference: progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain.

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenase

Managing Multi-center Flow Cytometry Data for Immune Monitoring

Modeling flow cytometry data for cancer vaccine immune monitoring

Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry

More than just tumor destruction: immunomodulation by thermal ablation of cancer

Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer.

Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient

Profiling of primary peripheral blood- and monocyte-derived dendritic cells using monoclonal antibodies from the HLDA10 Workshop in Wollongong, Australia

Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients

Radiofrequency ablation: the percutaneous approach

Report on the Fifth Annual Meeting of the Association for Immunotherapy of Cancer (CIMT) April 12–14, 2007 in Würzburg, Germany

Results of a Phase 1/2 Study in Metastatic Renal Cell Carcinoma Patients Treated with a Patient-specific Adjuvant Multi-peptide Vaccine after Resection of Metastases

Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols.

Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas

Soluble heat shock protein 70 members in patients undergoing allogeneic hematopoietic cell transplantation

T-cell dysregulation caused by chronic antigenic stress: the role of CMV in immunosenescence?

Targeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapy

The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study

The fungal ligand chitin directly binds and signals inflammation dependent on oligomer size and TLR2

Thinking outside the gate: single-cell assessments in multiple dimensions

Towards patient-specific tumor antigen selection for vaccination

Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas.

Validation of immunomonitoring methods for application in clinical studies: The HLA-peptide multimer staining assay

A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A24 and HLA-DRB111 alleles may be prognostic and predictive biomarkers for clinical benefit